TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006.

Mothaffar F Rimawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.